健保藥品的HTA評估報告
- 311 Epidyolex (Dravet 症候群 DS)
- 312 Epidyolex (結節硬化症 TSC)
- 313 莫帕滋膜衣錠、莫帕滋長效注射劑、瑞卡必持續性藥效注射懸浮劑 (Vocabria、Rekambys)
- 314 捷癌寧膜衣錠 (VERZENIO film-coated tablet)
- 315 拓達維注射劑 (TRODELVY for Injection)
- 316 Takhzyro solution for injection
- 317 Polivy
- 318 Imbruvica
- 319 奧妥凝凍晶注射劑 (Altuviiio Lyophilized powder for solution for intravenous injection 250 IU、500 IU、1000 IU、2000 IU)
- 320 Crysvita